Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06213376 · ClinicalTrials.gov registry record · NA
MIT Intensive Treatment Study
A NA study, sponsored by Nevada State University.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT06213376: Completed NA study, sponsored by Nevada State University.
NCT06213376 is a NA study that has completed, run by Nevada State University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06213376, a NA study, has completed, sponsored by Nevada State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is examining the use of intensive melodic intonation therapy and video feedback as a means of aiding individuals with nonfluent aphasia and co-occurring motor speech impairments. Individuals with nonfluent aphasia have difficulty with language, particularly with word retrieval.
Primary Outcome
Intelligibility as measured by percentage of consonants correct and by targets produced on trained and untrained stimuli. 20 trained and 20 untrained speech phrases that are relevant to the client (measured during reading and repetition tasks)
Interventions
- BEHAVIORAL Melodic Intonation Therapy
- BEHAVIORAL Video Feedback Performance Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-12-28 |
| Est. Completion | 2024-02-23 |
| Phase | NA |
What the finished NCT06213376 record still lists
NCT06213376 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Melodic Intonation Therapy is the first listed.
NCT06213376 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06213376 about?
NCT06213376 is a clinical study titled "MIT Intensive Treatment Study". This study is examining the use of intensive melodic intonation therapy and video feedback as a means of aiding individuals with nonfluent aphasia and co-occurring motor speech impairments. Individuals with nonfluent aphasia have difficulty with language, particularly with word retrieval.
What is the current status of trial NCT06213376?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2023-12-28. Estimated completion is 2024-02-23.
What interventions are being tested in trial NCT06213376?
The interventions under investigation include: Melodic Intonation Therapy (BEHAVIORAL), Video Feedback Performance Review (BEHAVIORAL).
Who is sponsoring clinical trial NCT06213376?
This trial is sponsored by Nevada State University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06213376's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI